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Abstract
Background: Genetic variations of the TCF7L2 gene are associated with the development of Type 2 diabetes (T2D).
The associated mutations have demonstrated an adaptive role in some human populations, but no studies have
determined the impact of evolutionary forces on genetic diversity in indigenous populations from Mexico. Here, we
sequenced and analyzed the variation of the TCF7L2 gene in three Amerindian populations and compared the
results with whole-exon-sequencing of Mestizo populations from Sigma and the 1000 Genomes Project to assess
the roles of selection and recombination in diversity.
Results: The diversity in the indigenous populations was biased to intronic regions. Most of the variation was low
frequency. Only mutations rs77961654 and rs61724286 were located on exon 15. We did not observe variation in
intronic region 4–6 in any of the three indigenous populations. In addition, we identified peaks of selective sweeps
in the mestizo samples from the Sigma Project within this region. By replicating the analysis of association with T2D
between case-controls from the Sigma Project, we determined that T2D was most highly associated with the
rs7903146 risk allele and to a lesser extent with the other six variants. All associated markers were located in
intronic region 4–6, and their r2 values of linkage disequilibrium were significantly higher in the Mexican population
than in Africans from the 1000 Genomes Project. We observed reticulations in both the haplotypes network analysis
from seven marker associates and the neighborNet tree based on 6061 markers in the TCF7L2 gene identified from
all samples of the 1000 Genomes Project. Finally, we identified two recombination hotspots in the upstream region
and 3’ end of the TCF7L2 gene.
Conclusions: The lack of diversity in intronic region 4–6 in Indigenous populations could be an effect of selective
sweeps generated by the selection of neighboring rare variants at T2D-associated mutations. The survivors’ variants
make the intronic region 4–6 the area of the greatest population differentiation within the TCF7L2 gene. The
abundance of selective peak sweeps in the downstream region of the TCF7L2 gene suggests that the TCF7L2 gene
is part of a region that is in constant recombination between populations.
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Background
Type 2 diabetes (T2D) is a leading global health problem.
The diabetic population is estimated to increase from 366
million to 552 million by the year 2030. T2D-related
genetic variants explain only a small portion of the herit-
ability of T2D. Ethnic differences in the prevalence of
T2D may be attributable to distinct genetic backgrounds
of these populations. High-throughput sequencing and
genotype data for ethnic groups other than those in which
most of the known variants have been discovered will
enable the discovery of new variants and an exploration of
their role in T2D [1]. Genetic variants of TCF7L2 have
been associated with T2D in nearly all ethnic groups stud-
ied [2–7]. TCF7L2 is a crucial transcription factor of the
Wnt signaling pathway; this pathway plays a role in devel-
opment and comprises a complex network of protein
interactions that regulate cellular intercommunication at
multiple levels [8]. TCF7L2 is most strongly associated
with T2D in populations of Caucasian origin [2]. Subse-
quent whole gene analyses of different populations, such
as Chinese [9, 10] and Mexican American populations
[11], have revealed other variants associated with T2D. In
addition, polymorphisms in the TCF7L2 gene that are as-
sociated with T2D exhibit patterns of variation and diver-
gence in concordance with natural selection in Caucasian
populations [12], but the relationship of this pattern to
metabolic characteristics is not completely understood
[13]. The effect of natural selection on this gene in a Latin
population is not known. Therefore, in this study, we in-
vestigated new variants in the TCF7L2 gene in a Mexican
population and analyzed the selective sweep patterns of
the TCF7L2 gene polymorphisms using exome-sequencing
data from the Sigma Project and 1000 Genomes Project.
Results
Mutations in the Mexican population
TCF7L2 is a transcription factor in the Wnt signaling path-
way and is expressed in many tissues, including fat, liver
and pancreatic islets of Langerhans [14]. Genetic variations
of the TCF7L2 gene, either in introns or exons, have been
associated with T2D, and these markers have been observed
in several individuals from different populations, including
the Mexican population [2, 15, 16]. Risk alleles associated
with gestational diabetes have also been identified in the
Mexican population, but the degree of Amerindian ancestry
in the subjects of these studies was unknown [17]. There-
fore, to estimate the variability of the TCF7L2 gene in a
Mexican population with high Amerindian ancestry, we se-
quenced three groups of indigenous people and one group
of mixed race from Mexico (See Methods) comprising 60
Mazatecan, 34 Nahua, 30 Zapotecan and 30 Mestizos.
Although the primers were designed primarily for
exons of the TCF7L2 gene (See Methods), most of the
variation identified in the Mexican population occurred
in introns, and only six variants were shared with the
1000 Genomes Project and the Sigma Project (Table 1).
We scanned the diversity of the TCF7L2 gene in 4,060
exomes (see Methods) and identified only 80 exonic var-
iants, corresponding to a nucleotide diversity of 0.00147
(data not shown). The low diversity is also reflected in the
allelic frequency of the rs77961654 (C/A) missense muta-
tion in exon 15, which was observed in the Indigenous
(Mexican) population, the 1000 Genomes Project, and the
Sigma Project (both cases and controls). The minor allelic
frequency (MAF) of rs77961654 (C/A) was lower in the
Sigma Project (0.0896552) than in the 1000 Genomes
Project (0.129793). Similarly, the MAF of the rs61724286
(C/G) polymorphism in exon 15 of the TCF7L2 gene in
the Indigenous population (Table 1) was lower in the
Sigma Project (0.000985222). The low MAF of the vari-
ants in exon 15 could suggest a purge of diversity in this
region; however, the intronic variants identified in the Indi-
genous populations, which were also observed in the 1000
Genomes Project, exhibited a heterogeneous MAF. In
particular, variants rs176632 (T/C) and var_10_114919595
(C/T) in intron 9 exhibited MAFs of 0.992412 (high) and
0.002396 (low), respectively. This heterogeneity in MAF
(0.1984 and 0.000399) was also observed in the variants
rs56913138 (G/T) and rs188695269 (G/A) in intron 6
(Table 1) and could be a footprint of selective processes of
ancestral variants.
The majority of mutations identified in the Indigenous
population were new and were located in noncoding
regions (Table 2), particularly in introns 4, 6, 7, 11, 13, and
15, it was not possible to calculate the MAF based on the
1000 Genomes Project or Sigma Project. Due to the low
number of mutations observed in the Indigenous popula-
tion, these variations can be referred to as rare genetic
variants. It has been hypothesized that mutations with a
MAF of 0.5 – 1 % (lower frequency) and rare variations
explain a substantial fraction of the heritability of com-
mon, complex diseases [18]. In the exome-sequencing, the
excess of rare variations was consistent with explosive hu-
man population growth [19], and most of the mutations
with functional impact were maintained by weak purifica-
tion [20]. We assessed the functional impact of two exonic
variants (rs77961654 and rs61724286) in the Indigenous
population (see Methods) and did not find a deleterious
impact of the TCF7L2 gene in either case. The lack of
deleterious mutations (modify the function of the protein)
suggests some type of selection inside of the gene.
Selection and recombination
To observe selection effects, we analyzed the sweep pat-
terns in a region that included 1 megabase around the
TCF7L2 gene using data from the Sigma Project (see
Methods). The selective sweeps predict the pattern of ex-
cessive linkage disequilibrium (LD) in each of the two
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Table 1 Mutations identified in the Indigenous population and shared with the Sigma and 1000 Genome Projects. * Frequencies sorted by cases: controls; cases are defined as
patients with type 2 diabetes
1000 Genomes Project Sigma Project Indigenous people








Intronic 6 Gene 191193 rs56913138 Chr10 114901201 114901201 G T
0.000399 2503(G/G)/
1(G/T)/0(T/T)




Intronic 9 Gene 201071 rs176632 Chr10 114911079 114911079 T C
0.002396 2498(C/C)/
6(C/G)/0(G/G)




0.0896552 C/C = 1564:1618
C/A = 331:320
A/A = 10:16
Exonic 15 Gene 215361 rs77961654 Chr10 114925369 114925369 C A
0.000985222 C/C = 1901:1950
C/G = 4:4
Exonic 15 Gene 215363 rs61724286 Chr10 114925371 114925371 C G
aGenotypes

















Gene Gene coordenate dbSNP138 Chr Start End Ref Obs
Intronic 4 TCF7L2 14402 Chr10 114724410 114724410 T A
Intronic 4 TCF7L2 14404 Chr10 114724412 114724412 G C
Intronic 6 TCF7L2 191411 Chr10 114901419 114901419 A T
Intronic 6 TCF7L2 191412 Chr10 114901420 114901420 T G
Intronic 6 TCF7L2 193490 Chr10 114903498 114903498 A C
Intronic 6 TCF7L2 193491 Chr10 114903499 114903499 C A
Intronic 7 TCF7L2 193908 Chr10 114903916 114903916 C A
Intronic 7 TCF7L2 193913 Chr10 114903921 114903921 T A
Intronic 7 TCF7L2 193940 Chr10 114903948 114903948 G C
Intronic 7 TCF7L2 193951 Chr10 114903959 114903959 G T
Intronic 7 TCF7L2 193967 Chr10 114903975 114903975 G A
Intronic 7 TCF7L2 193975 Chr10 114903983 114903983 G T
Intronic 7 TCF7L2 193982 Chr10 114903990 114903990 C A
Intronic 7 TCF7L2 193987 Chr10 114903995 114903995 G C
Intronic 7 TCF7L2 193988 Chr10 114903996 114903996 C A
Intronic 7 TCF7L2 193995 Chr10 114904003 114904003 G C
Intronic 7 TCF7L2 194007 Chr10 114904015 114904015 T A
Intronic 7 TCF7L2 194012 Chr10 114904020 114904020 G T
Intronic 7 TCF7L2 195524 Chr10 114905532 114905532 C G
Intronic 11 TCF7L2 207481 Chr10 114917489 114917489 G C
Intronic 11 TCF7L2 207483 Chr10 114917491 114917491 T A
Intronic 11 TCF7L2 207485 Chr10 114917493 114917493 T C
Intronic 11 TCF7L2 207486 Chr10 114917494 114917494 G A
Intronic 11 TCF7L2 207487 Chr10 114917495 114917495 G A
Intronic 11 TCF7L2 207488 Chr10 114917496 114917496 G C
Intronic 11 TCF7L2 207492 Chr10 114917500 114917500 G T
Intronic 11 TCF7L2 207495 Chr10 114917503 114917503 T G
Intronic 11 TCF7L2 207497 Chr10 114917505 114917505 G C
Intronic 11 TCF7L2 207499 Chr10 114917507 114917507 C A
Intronic 11 TCF7L2 207500 Chr10 114917508 114917508 A T
Intronic 11 TCF7L2 207501 Chr10 114917509 114917509 A G
Intronic 11 TCF7L2 207502 Chr10 114917510 114917510 T A
Intronic 11 TCF7L2 207504 Chr10 114917512 114917512 G A
Intronic 13 TCF7L2 209536 Chr10 114919544 114919544 A T
Intronic 13 TCF7L2 209555 Chr10 114919563 114919563 T A
Intronic 13 TCF7L2 209562 Chr10 114919570 114919570 C T
Intronic 13 TCF7L2 209571 Chr10 114919579 114919579 A G
Intronic 15 TCF7L2 215224 Chr10 114925232 114925232 A T
Intronic 15 TCF7L2 215229 Chr10 114925237 114925237 G T
Intronic 15 TCF7L2 215230 Chr10 114925238 114925238 G C
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regions that flank a recently fixed beneficial mutation by
strong positive selection [21]. The Cross Population Ex-
tend Haplotype Homozygosity Test (XPEHH) is highly
powerful in detecting those with approximately fixed or
fixed selected loci [22] and given the association of LD
patterns and selective sweeps, we calculated statistics r2 and
XP-EHH (see Methods) and we found that the values
significant of r2 (higher > 0,6) in Latino population, flanked
to regions with a strong positive selection (values significant
of XP-EHH). It is worth mentioning that most of selected
regions only in the Latino population (values positive of
XP-EHH) were localized in regions adjacent to TCF7L2
gene. The upstream region included the genes MIR4295
and VTI1A, while the downstream region harbored the
genes DCLRE1A and NHLRC2. This downstream region
was located within of a block hard selection sweeps, which
covers several genes involved in metabolism, for example,
genes PLEKHS1 and MIR4483. However, the values signifi-
cant of r2 were found in a region of soft selection sweeps in
TCF7L2 gene (Additional files 1, 2 and 3) . In a context of
disease association, the r2 statistic is often used in calcula-
tions of power to detect disease-susceptibility loci [23].
In making the case–control association study using the
data from the Sigma Project (see Methods), we found
several risk alleles reported before (Fig. 1). For example,
the rs7903146 risk allele exhibited a high association with
T2D and has been associated with Mexican and Asian
populations [1, 24]. Other possible risk alleles (rs7896811,
rs11196199, rs114863326, rs11196203, rs72826075 and
rs35011184) were located within the cutoff limits from the
Manhattan plot, and although no studies have linked these
mutations with T2D, a duplication of this region (including
the mutations described above) has been associated with in-
tellectual and developmental disabilities [25]. The values of
r2 in the intronic regions (1 to 4) of the TCF7L2 gene were
less than 0.4 when we used only the African population. By
contrast, we observed an increase in the values of r2
(Fig. 1b) in the same region when we used only the
Fig. 1 Dynamics of selective sweeps, recombination rate and linkage disequilibrium (LD) in the chr10:113925369–115925369 region (a) and
(b), The y axis on the left side is the negative logarithm of the p-value of association of case-controls of the Sigma Project samples. The y axis on
right side is the recombination rate (cM/Mb) calculated by the 1000 Genomes Project. The recombination peaks are represented by the solid blue
line. r2 was 0–1 and was calculated for the African population only. The color spectrum of the spheres is a function of the r2 value. (c) The first
segment is the genomic coordinates of chromosome 10 based on mutations identified in the Indigenous population and the selective sweep
peaks determined only from the Sigma Project samples. The dashed black circles indicate overlap of the recombination hotspots with the
selective sweep peaks. The second segment represent the location in chromosome 10 of the hits of the Sigma Project mutations against the
GWAS databases. The third segment includes mutations associated with T2D. Red indicates associated mutations, and blue indicates mutations
inside the limit cutoff of the Manhattan plot. The fourth segment is the genomic context of the analyzed region, with the exons and introns of
each gene. The x axis shows the coordinates of chromosome 10
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American population, and the range of values of r2 was 0.1
to 1. This increase in r2 could be related to the association
with T2D. Moreover, due to the characteristics of the Sigma
Project samples (ancestry controlled), the correlation be-
tween the loci associated with T2D in the intronic regions
could be under selective constraints in the Amerindian
populations. The TCF7L2 gene is located between two re-
combination hotspots (solid blue line in Fig. 1a and b). The
first hotspot is upstream of the TCF7L2 gene and begins in
the VTI1A and LOC103344931 genes. The second hotspot
is located in exon 14 of the TCF7L2 gene. Most of the in-
tronic variants from the Indigenous population (Fig. 1c)
were located in the second recombination hotspot; how-
ever, no selective sweep peak was observed in this hotspot.
The sweep peaks in the TCF7L2 gene were located in exon
5 and intronic region 5–6 (Fig. 1c). The exon 5 peak, was
flanked by the r2 significant values and it was found in a ad-
jacent region with XP-EHH significant values (Additional
files 1, 2 and 3). These sweep peaks were previously associ-
ated with T2D and could explain the decrease in variability
in the Sigma Project samples and the lack of variability in
the Indigenous population in this particular region.
Across the entire region analyzed we observed sev-
eral recombination hotspot peaks (solid blue line in
Fig. 1c); however, we identified overlap between the
selective sweep peaks (identified for several methods,
Additional files 1, 2 and 3) and the recombination
hotspots (elliptic dashes in Fig. 1c). The first zone of
overlap was located between the upstream and down-
stream regions of the ZDHHC6 gene and included
two hotspots. The second zone of overlap was larger
than the first and contained the HABP2, NRAP,
CASP7, PLEKHS1, MIR4483, DCLRE1A and NHLRC2
genes. This zone also included two recombination
hotspots. The segment delimited by both zones had hits
with a GWAS database (Fig. 1c), including associations
with breast cancer, T2D and serum dimethylarginine
levels. The upstream region of the HABP2 gene is associ-
ated with migraines without aura, and the intergenic re-
gion between the PLEKHS1 and MIR4483 genes is
associated with obesity − related traits. These associations
with disease may be due to lower frequencies or the action
of purifying selection to maintain the sweep patterns ob-
tained from the recombination.
Genomic distribution of mutations in the Indigenous
population
Purifying selection acts not only in the coding regions of
the TCF7L2 gene but also in the introns. As a result of
selection, we observed only 1,137 variants along two
megabases of chromosome 10 (including TCF7L2) of the
Sigma Project exomes (data not shown). We observed a
decrease in the variability of the TCF7L2 gene (80 vari-
ants) in the Indigenous population. The localization of
SNPs along TCF7L2 gene was not constant, i.e., regions
with low and high density of mutations were observed.
The last exons (6–14) of the gene harbored the higher
density of SNPs (Fig. 2a). We observed the same distri-
bution of SNPs in the Indigenous population as in the
Sigma samples; most of the variants were located in in-
tronic areas. Therefore, we searched the intronic SNPs
in RNA databases (see Methods). We did not observe
hits of the intronic variants against human mRNAs, des-
pite the higher density poly(A)-sequencing in the last
exon of the TCF7L2 gene (Fig. 2b), where the variation in
the Indigenous population was concentrated. The same re-
sult was obtained when we searched intron variants in the
regulatory sites database at http://mirdsnp.ccr.buffalo.edu/
browse-genes.php. However, more than one causal variant
associated with T2D was located in introns 4–6; for ex-
ample, the rs7903146 risk allele (described above) had an
effect on enhancer activity, resulting in higher TCF7L2
gene expression [26]. Comparing the sequence of the
TCF7L2 gene against the Neanderthal genome (http://
neandertal.ensemblgenomes.org/Homo_sapiens/Loca
tion/Genome) (Fig. 2c) revealed a random distribution
of variants. The intronic region (4 to 6) provided an ag-
glomeration of selected mutations (selection scanning).
This agglomeration may suggest selection before the
Neanderthal-human speciation. At the human population
level, the intronic region of 4 to 6 exhibited greater
differentiation in SNP patterns (bottom of Fig. 2d). This dif-
ferentiation could be the product of the action of selective
sweeps in fixing low-frequency mutations associated with
T2D.
Haplotype patterns and phylogenetic networks
Allelic frequencies are subject to selective and recombin-
ation processes. For example, the diversity pattern of the
rs7903146 risk allele suggests a positive selective sweep
that may have rapidly driven fixation in East Asians and
decreased the frequencies in Europeans and Africans
[12]. We observed an extension of the positive selective
sweep near the rs7903146 SNP comprising the intronic
region 4 to 6, and a possible effect of this extension
would be a decrease in the frequencies of the SNPs asso-
ciated with T2D (rs7896811, rs11196199, rs114863326,
rs11196203, rs72826075 and rs35011184). To determin-
ate the relationships among the different haploid geno-
types associated with T2D, we performed a network
haplotype (see Methods). For this analysis, we included
the genotypes of macaque, orangutan and chimpanzee,
with the latter as the outgroup (Root). Although we in-
cluded a root (Outgroup) on network (Fig. 3), all internal
nodes exhibited reticulations, hindering the interpret-
ation of the hypothetical ancestors. The internal nodes
that surrounded the root were grouped (green dashes)
by their haplotype profiles. The European haplotype
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pattern presented major frequencies, including at the
rs7903146 SNP. Other groups (Fig. 3, blue dashes) were
formed from haplotype 00100, producing nodes with lower
frequencies in the African populations. The rs7903146 risk
allele was located in all networks, suggesting that it is an
ancestral haplotype and possibly fixed in all populations;
however, this risk allele was not derived from the root
(chimpanzee). By contrast, the possible rs114863326 risk
allele was observed between the nodes from the chimpan-
zee and macaque and was located only in the African
population group (blue dashes). The predominance of
rs114863326 within the African group would suggest a
possible selective sweep to each population mediated by
intra-species recombination.
The reticulations on the internal nodes are produced
by recombination effects. The rapid growth of the hu-
man population also facilitated the spread of rare vari-
ants among different races. The presence of
recombination hotspots inside and outside the TCF7L2
gene suggests constant genetic flow, and the phylogen-
etic interpretation is consequently unclear. We therefore
constructed a NeighborNet tree (see Methods) based on
the variation obtained from the 1000 Genomes Project.
As shown in Fig. 4, two principal groups were formed,
each including several types of human populations. This
phylogenetic incoherence was derived from the reticula-
tions (dashes red) within and between both groups. Des-
pite the reticulations, small groups maintained coherence
(Fig. 4), for example, the Indian population with cluster A
(ITU, Karimnagar) and B (GIH-ITU, Gandhinagar and
Karimnagar). Cluster C included a Japanese population
(JPT). These clusters with phylogenetic coherence suggest
that the majority of the observed recombination events
are ancient.
Discussion
TCF7L2 harbors variants with the strongest effect on T2D.
The phenotypic changes associated with the risk genotype
suggest that T2D arises as a consequence of impairment of
several vital functions in the pancreatic islet [27]. In
addition, the synthesis and processing of proinsulin and
possibly the clearance of proinsulin and insulin are
Fig. 2 Distribution and patterns of SNPs in the TCF7L2 gene. At the top is the x axis, which comprises the coordinates of chromosome 10. a) Distribution
of SNPs identified in the Indigenous population along the TCF7L2 gene; mutations identified in the Sigma Project and UCSC gene description, i.e., the
number of exons and introns. b) Human mRNAs, the location of mRNA along the TCF7L2 gene; Splice ETs, chromosomal position of Human ETs with
splice; Human ETs, distribution of human Ets; Poly(A) sites, dispersion of sites associated along a tissue-specific region; UniGene, alignments of all mRNA
and EST tracks from TCF7L2 transcription; TFBS (Transcription Factor Binding Sites) conserved, in the figure, each box represents one site conserved in the
human/mouse/rat alignment; TargetScan miRNA Regulatory Sites, this track shows conserved mammalian microRNA regulatory target sites in the 3’ UTR
regions of TCF7L2. c) Genomic location of variants used in the identification of selective sweeps in the Neanderthal genome. Dashed red circles indicate
mutations that are under selective sweeps. d) Genetic differentiation and patterns of variation in the TCF7L2 gene identified in the 1000 Genomes Project
for all populations
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regulated by TCF7L2 [28]. Due to the functional import-
ance of TCF7L2, any mutation in either the coding or non-
coding regions could change its function. Recently, the
common noncoding variant rs7903146 (risk T-allele) was
associated with increased TCF7L2 expression and de-
creased insulin content and secretion [28]. This variant has
been associated with T2D in several ethnic groups, such as
Japanese, Indian, Tunisian, European and Mexican [1, 24,
29–31]. By replicating the case–control association analysis
from the Sigma Project, the rs7903146 risk allele was also
associated with T2D, and other possible risk alleles
placed on introns 4–6 (rs7896811, rs11196199,
rs114863326, rs11196203, rs72826075 and rs35011184)
were located in the limits of the cutoff values of the
Manhattan plot. The presence of the rs7903146 SNP in
several populations may suggest an ancestral character;
however, the association of this variant with T2D in
populations with controlled ancestry might suggest an in-
creased rate of recombination in a specific population.
The dispersion of the possible risk allele rs35011184 in a
given population may be mediated through recombination
or by the occurrence of new mutations within the region
[32, 33]. Although LD has been reported in the TCF7L2
gene, rs7903146 exhibited moderate LD in the European
populations (r2= 0.73) [34]. By contrast, we observed
higher LD of the 4–6 intronic region (including
rs7903146) associated with T2D (0.5 to 1) in the Latino
population (r2= 0.5 to 1) than the African population (r2=
0.2 to 0.5), and the SNPs in LD were not associated with
T2D, suggesting a vertical inheritance of genotypes.
Phylogenetic analysis of exon 4 suggested that the
rs7903146 risk allele is an ancestral character and tends to
recombine with a variety of haplotype backgrounds, par-
ticularly in the relatively diverse West African population
Fig. 3 Network median joining. Haplotype network based on the sequences of variants (rs7903146, rs7896811, rs11196199, rs114863326, rs11196203,
rs72826075 and rs35011184) of the samples of the 1000 Genomes Project associated with T2D. The nodes are the haplotype profiles and mv-nodes
are the missing haplotypes. The outgroup included nucleotides from chimpanzee, root, macaque and orangutan. Each color indicates a possible
haplotype profile; the color was randomly assigned. The size of the sphere is related to the frequency of the haplotype patterns. The dotted blue line
includes the haplotypes from the African population, and the dotted green line contains the haplotype patterns of the European population. The
bottom left of the figure shows the populations included in the network. The bottom right lists the mutations associated with T2D from the
Sigma Project.
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[12]; however, the analyses of Network median joining of
the intronic variants indicated an increase in the recom-
bination of rs7903146 because it was mainly placed in two
of the groups. Moreover, the possible risk allele
rs114863326 also exhibited ancestral character and was lo-
cated next to the root taxon (chimpanzee). Notably, this
variant was only localized in a cluster of the African popu-
lation, suggesting that this variant tends to recombine with
this group. The increase in reticulations in the haplotype
network in the intronic regions could indicate a decrease in
selection forces compared to the coding regions; however,
we did not observe differences in the reticulations of the
neighborNet tree from 6,061 variants (in the TCF7L2 gene)
in mostly exonic regions obtained from the 1000 Genomes
Project. The only phylogenetic consistency was observed in
small groups belonging to the same population. The excess
of phylogenetic inconsistency across the TCF7L2 gene
could be the result of recombination hotspots in the sur-
rounding region (1 Mb) of the TCF7L2 gene. In particular,
two recombination peaks flank the gene at the 5’ and 3’
ends. Some apparent recombination hotspots could be an
artifact of variable population size over time (demographic
effects) because these hotspots were identified assuming a
particular model of human history, and one of the
Fig. 4 NeighborNet. Network analysis was based on 6061 mutations in the TCF7L2 gene identified from the samples of the 1000 Genomes
Project. The dashed red circles indicate the reticulations between the nodes. The letters a, b and c are clusters with phylogenetic coherence.
The scale is located at the bottom of the network and shows their substitutions by site
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assumptions of that model is that the effective population
size of humans has remained constant throughout history
[35]. The inferred recombinant hotspots in gene regions
that also appear to have undergone positive selection [36]
may not be due to non-uniform densities of meiotic recom-
bination but may simply be a by-product of positive selec-
tion. Therefore, selective sweeps do make a significant
contribution to the patterns of LD in the human genome
[37].
Selective sweeps can increase the genetic differentiation
among populations, cause allele frequency spectra to depart
from the expectation under neutrality, and also alter the al-
lele frequencies of single nucleotide polymorphisms (SNPs)
in the vicinity of the selected allele [38]. We observed two
peaks of selective sweeps in exon 5 and intron region 5–6
of the TCF7L2 gene in samples from the Sigma Project with
Amerindian ancestry greater than 70 %. This peak is within
intron region 4–6 (associated to T2D), which covers
approximately 81 % (178,063 bp) of the TCF7L2 gene.
Because more than half of the gene is constantly under
sweep selection, the reduction or elimination of variation
among the nucleotides in neighboring regions could explain
why most of the mutations (40 variants) observed in the
Amerindian population occurred in intron 7 to 15 and why
only six mutations were observed in introns 4 and 6. Forty
of the mutations were not observed in the 1000 Genomes
Project or the Sigma Project, and all had a low frequency
(rare variants). Moreover, four of the variants were identi-
fied in the 1000 Genomes Project, and the rs176632 (T/C)
and rs56913138 (G/T) SNPs exhibited a MAF of 0.99 and
0.19, respectively. In the Sigma Project, the two mutations
(rs77961654 C/A and rs61724286 C/G) in exon 15 exhib-
ited the lowest MAF of 0.08 and 0.0009, respectively. All
mutations in the Amerindian population identified in both
databases (1000 Genomes Project and Sigma Project) are of
ancestral character and survived genetic drift, possibly by
strong positive selection. Most of the peaks of selective
sweeps were identified downstream of the TCF7L2 gene,
including the following genes: HAPB2, NRAP, CASP7,
PLEKHS1, MIR4483, DCLRE1A and NHRLC2. This region
was associated with diseases from the GWAS catalog such
as obesity-related traits and Gaucher disease severity. In
addition, the peaks of selective sweeps overlapping with
recombination hotspots could influence the selection of the
TCF7L2 gene.
The impact of the TCF7L2 gene on metabolic dis-
eases is fundamental because this gene has multiple
targets in the pathways for insulin synthesis [28]. The
hepatic expression of TCF7L2 is decreased in diabetic
patients as their body mass index (BMI) increases
[39]. Moreover, studies in mice have revealed that the
regulation of TCF7L2 expression varies in different tissues.
In mice fed a high fat diet (HFD), the expression levels of
TCF7L2 were upregulated in pancreatic islets but down-
regulated in the liver [40]. Furthermore, the TCF7L2 gene
displays a complex pattern of spliced variants, with several
alternative exons and splice sites, resulting in splice vari-
ants that are distributed and expressed in a tissue-specific
manner [41–44]. The presence of the rs61724286 (C/G)
splice variant identified in Zapotecan and mixed race
(group with less Amerindian ancestry) populations in con-
junction with the rs77961654 (C/A) missense variant
(present in three indigenous populations) may not be tol-
erable for function of the TCF7L2 gene. The function of
this gene is also impacted by the high-fat, caloric-dense di-
ets and sedentary lifestyles common in our society. Al-
though most mutations surviving the processes of
selective sweeps in the Indigenous populations were in-
tronic and had no immediate functional impact, the accu-
mulation of mutations, particularly in exon 15, could have
a damaging effect on the regulation of metabolism by the
TCF7L2 gene.
Conclusions
The TCF7L2 gene is the locus most strongly associ-
ated with T2D risk in different populations [26]. In
addition, evidence of LD and mutations in the
TCF7L2 gene [34] that are under selective processes
exist [12]; however, ancestry has not been controlled
in most studies, and evolutionary processes in Amer-
indian populations have not been evaluated. In this
work, we identified and analyzed the nucleotide vari-
ants in three indigenous populations: Mazatecan,
Nahua and Zapotecan. Although the number of sam-
pled individuals in each of the three groups was low
(30–60) and varied, the high Amerindian ancestry of
the indigenous population allowed us to detect
changes in the allelic frequencies in the Mexican
population (Sigma Project) and the rest of the human
population (1000 Genomes Project). Thus, we ob-
served an asymmetric distribution of nucleotide vari-
ants in the 5’ and 3’ ends of the TCF7L2 gene. Most
of the mutations were located within intron 6–7 on-
wards. The only two coding mutations were located in
exon 15. The lack of diversity in the Indigenous populations
in intronic regions 1–6 could be due to a selective sweep
because we identified two selection peaks in the samples
from a Mexican Mestizo population (Sigma Project) with
Amerindian ancestry higher than 70 %. The first peak was
located in exon 5, and the second was located in intron 5–
6. Additionally, the two selective peaks were placed within
the area (intronic 4–6) containing mutations associated
with T2D, including the rs7903146 risk allele, which was
the most frequent allele not only in the samples from the
Sigma Project but also in the various human populations.
The reticulations identified in the network analysis, either
in the variants associated with T2D or all of the variants of
the TCF7L2 gene in the samples of the 1000 Genomes
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Project, suggest that the dispersion of rs7903146 in human
populations is due to recombination. This hypothesis is
supported by the recombination hotspots located in the up-
stream region and 3’ end of the TCF7L2 gene. Furthermore,
the overlap of the sweep peaks with the recombination hot-
spots in the area downstream of the gene, specifically in an
area associated with obesity-related traits and Gaucher dis-
ease severity, indicates that the TCF7L2 gene is part of a
strongly selected region in which rare variants that survive




The Amerindian population, based on self-reporting,
comprised 60 Mazatecan from San Lorenzo Cuaunecuil-
titla, Oaxaca (Mexico), 34 Nahuas from Xoteapa, Vera-
cruz (Mexico) and 30 Zapotecan from the Mexican
Diversity Project. Henceforth, these populations are re-
ferred to as the Indigenous population. Another group
of 30 mixed-race Mexicans (Mestizo population) from
the Mexican Diversity Project [45] participated. All indi-
viduals gave informed consent before they were included
in the study. Mestizo and Zapotecan participants gave
written consent. Verbal consent from Nahua population
was taken and written consent from Mazatecan popula-
tion was taken. Mestizos and Zapotecan samples were
taken with anonymazed consent; All the individuals were
18 years or older. The age range was: Nahua from 37 to
81 years old, Mazatecan from 22 to 78 years old.
Sequencing
DNA was extracted using the QIAamp DNA Blood Maxi
Kit, QIAGEN. We designed primers for each exon that
also covered part of the introns surrounding the exon
(Additional file 4). Sequencing was performed using the
Sanger method on an Applied Biosystems sequencer
(3730xl DNA Analyzer) with Big dye terminator (stand-
ard method).
Databases
The variability (SNPs) of chromosome 10 was obtained
from the 1000 Genomes Project ((v4.20130502) ftp://
ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/). This
project contains five super-populations: African (AFR), Ad
Mixed American (AMR), East Asian (ASN), European
(EUR), and South Asian (SAN). The numbers of sampled
individuals were 661, 347, 504, 503 and 489, respectively.
The family relationship is included in the *.bed files along
with the gender and geographic origin of the individuals.
To assess variability inside the Latino population, par-
ticularly on chromosome 10, we used the Sigma Project
database [1], which includes 4,060 whole-exome sequences
of individuals. This database consists of 1954 controls, 1905
T2D cases and 201 individuals without ascertainable
clinical histories. The Sigma Project comprises four data-
bases: DMS (Diabetes in Mexico Study), MCDS (Mexico
City Diabetes Study), MEC (Multiethnic Cohort) and UIDS
(UNAM/INCMNSZ Diabetes Study). We used the UIDS
database because of the protocols used to identify individ-
uals with T2D. Cases were recruited at the outpatient dia-
betes clinic of the Department of Endocrinology and
Metabolism of the Instituto Nacional de Ciencias Médicas
y Nutrición Salvador Zubirán (INCMNSZ). An important
feature of this database is that the Amerindian ancestry of
the individuals was higher than 70 % (ancestry was calcu-
lated previously by exome-chip sequencing). A high
Amerindian ancestry eliminates the influence of other
populations in the genetic analysis. The analyzed sequence
included only the coding regions (exome-sequencing) and
also spanned the intronic regions adjacent to exons.
Determination of SNPs
The quality of Sanger sequencing (q-value) of the Indigen-
ous populations was assessed by the fastqc program [46],
with pretreatment of the reads using in-house Python
scripts. The sequencing chromatograms were analyzed by
the PolyPhred program [47]. We used a minimum q-value
of 20 and the following parameters: −f 16, −score 90, −win-
dow 15. The output PolyPhred was processed by perl
scripts [48] for mutation screening. The dbSNPs database v.
138 [49] was used to annotate the SNPs identified by the
perl scripts.
Association of case–control
Replication of the association test of case–control for T2D
in Latinos with Amerindian ancestry greater than 70 % (de-
scribed above) was performed by the plink program [50]
with the parameters provided in the Sigma Project [1].
Genomic region for evolutionary analysis
The area of study for selective sweep analysis and re-
combination focused only on chromosome 10 because
this region harbors the TCF7L2 gene. The region was
defined by referring to the human genome (hg19 ver-
sion) and delimited with the coordinates: 113,925,369 –
115,925,369. This region encompasses the following
genes: GPAM, TECTB, MIR6715A, MIR6715B, GUCY2GP,
ACSL5, ZDHHC6, VTI1A, MIR4295, LOC103344931,
TCF7L2, HABP2, NRAP, CASP7, PLEKHS1, MIR4483,
DCLRE1A, NHLRC2, ADRB1 and CCDC186.
Identification of selective sweeps
Based on the variation identified in chromosome 10 from
the whole-exome-sequencing of the Sigma Project (de-
scribed above), we constructed a nucleotide sequence com-
posed mainly of variation (SNPs) for each individual. If a
mutation was not observed at a particular position for an
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individual in the alignment of all samples, we used the
existing nucleotide in the hg19 reference genome (The
Genome Sequencing Consortium). This process com-
prised two parts. First, we extracted the nucleotide
variation for each individual using the pseq program
[50] with flags v-view –geno –mask. Next, the nucleo-
tides were concatenated through perl scripts without los-
ing the order of chromosome 10. In the second part, we
revised and formatted the alignment to analyze selective
sweeps using perl scripts. Selective sweeps were identified
by traditional and whole-genome tools.
The traditional tests used: iHS [51], XPEHH [51] and
nSL [52]. The iHS scores were calculated and normalized
using selscan program [53] with parameters: −-max-extend
1000000 (maximum EHH extension in bp), −-max-gap
300000, −-gap-scale 30000, −-cutoff 0.05 (EHH decay cut-
off) and –alt. We used the recombination map of Altshuler
[54]. The output results for each SNP were then frequency-
normalized over chromosome 10 using the script norm,
provided with Selscan. This normalization was also done
using default parameters: −-bins 100 (number of frequency
bins). The fractions of SNPs with |iHS| values above 2.0
were retained.
The nSL scans were performed and normalized using
Selscan program [53] following the same procedures used
for iHS. The iHS statistic compares the integrated EHH
(Extended Haplotype Homozygosity) profiles between two
alleles at a given SNP in the same population. It is note-
worthy that the nSL test uses a slightly different approach
to screen for EHH than the original iHS test and is robust
to variation in recombination frequency, also identify
selective peaks under a number of different selection
scenarios, most notably in the cases of sweeps from stand-
ing variation and incomplete sweeps [52].
The XP-EHH (Cross Population Extended Haplo-
type Homozygosity) statistic compares the integrated
EHH profiles between two populations at the same
SNP [55] and is expected to be more reliable if a ref-
erence population with a similar demographic history
is available, and if the allele under selection is close
to fixation in one of the populations. XP-EHH score
were calculated by Selscan program [53] with parame-
ters: −-xpehh –max-gap 300000 –gap-scale 30000 and
–alt. We compared Latino population vs African
population reference of the 1000 Genomes Project.
The scores for each SNP were then frequency-
normalized over chromosome 10 using the script
norm, provided with Selscan. We fit the XPEHH
scores distribution using General model Gauss with
one component by Matlab program [56]. Since that
the negative XPEHH suggest selection happened in
reference population, we identified the two Gauss dis-
tribution tails with 95 % confidence. SNPs passing posi-
tive threshold are candidates for selection in Latino
population and those passing negative threshold are in Afri-
can population.
The whole-genome tools: The ω statistic proposed by
Kim and Nielsen [21] was able to accurately localize the
selective sweeps by a likelihood (ML) framework that
uses linkage-disequilibrium (LD) information. Omega-
Plus program [57] has a high-performance implementa-
tion of the ω statistic at genome level and was utilized
for scan to chromosome level the selective sweeps, with
parameters -grid 47370, −minwin 1, −maxwin 5,
−threads 20, −impute N, −seed 20, and -all. The peaks
of selective sweeps from OmegaPlus were those that
exceeded the upper confidence interval calculated by the
function dfittool from the Matlab program [56].
Calculation of linkage disequilibrium (LD) and integration
of genetics analysis
LD was calculated for chromosome 10, particularly for the
regions of the TCF7L2 gene. We extended this region
1000 kb downstream and upstream of the TCF7L2 gene
(described above). The plink program [50] was used with
default parameters; however, to rule out the influence of
non-Latino populations, we calculated LD based on the
African population of the 1000 Genomes Project (because
it is the oldest population) and another analysis with the
Latino population only.
The mutations from the Sigma Project localized to the
extended region (described above) and were searched
against a GWAS database to identify the diseases associ-
ated with this genomic region. Additionally, the peaks of
selective sweeps (determined above) and mutations of
the Indigenous population previously identified were in-
tegrated by the LocusZoom program [58].
Haplotype network and phylogenetic network analysis
To determine the relationships among the different
genotypes associated with T2D (describe above), we
performed Network median joining using the Network
program [59]. We used the following modules: Start
contraction, Median joining and MP calculation. For the
Outgroup, we included orangutan (GCA_000001545.1),
chimpanzee (GCA_000001515.4) and macaque (MMUL
1.0) sequences. Mutations in the TCF7L2 gene (6,061
mutations) from the 1000 Genomes Project were
concatenated, and a fasta file was constructed. Next, a
neighborNet tree was constructed by the Splistree pro-
gram [60] using default parameters.
Functional impact of mutations
The mutations were analyzed based on their genomic
coordinates in the ANNOVAR [61] and SNPSIFT [62]
databases. Both databases include several algorithms (nine
in all) that predict the functional effect. We selected a
mutation if it was positive in at least 4 algorithms. The
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filters were numbers or letters as follows: POLYPHEN2
(“P and D”), LRT (“D” and “ < 0.0001”), MutationTaster
(“A and D”), MutationAssessor (“high, medium and low”),
FATHM (“ < −1.5”), GERP++ (“ > = 5”), SIFT (“ < 0.05”),
phylop (“ > = 3”) and PROVEAN (“ < −2.5 Deleterious
probably” and “ < −4.1 Deleterious”).
Effects of mutations on gene expression
The SNPs could create, destroy, or modify the efficiency
of miRNA binding to the 3’UTR of a gene, resulting in
gene dysregulation. Consequently, we explored each muta-
tion identified in the Indigenous population in the following
databases: miRdSNP [63], mrSNP [64] and RNAsnp [65].
We plotted our results using the UCSC browser (http://
genome.ucsc.edu/cgi-bin/hgGateway).
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